Article
No relevant cognitive sequelae one year after STN-DBS in patients with GBA1-PD - subanalysis of a prospective cohort study
2026-07-14
Abstract excerpt
<title>Abstract</title> <p>Background Heterozygous GBA mutations represent the most common genetic risk factor for Parkinson’s disease (PD) and can be associated with a more aggressive phenotype and an increased risk of cognitive impairment. Although subthalamic nucleus deep brain stimulation (STN-DBS) provides sustained motor benefit, concerns remain regarding its cognitive safety in GBA1-associated PD (GBA1-PD...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4d86f82c-b69a-5f11-94db-db6539f94777
- DOI
- 10.21203/rs.3.rs-10266952/v1
